Abstract:The mitogen-activated protein kinase/extracellular signal-regulated (MAPK/ERK) pathway is activated by upstream genomic events and/or activation of multiple signaling events in which information coalesces at this important nodal pathway point. This pathway is tightly regulated under normal conditions by phosphatases and bidirectional communication with other pathways, like the protein kinase B/mammalian target of rapamycin (AKT/m-TOR) pathway. Recent evidence indicates that the MAPK/ERK signaling node can function as a tumor suppressor as well as the more common pro-oncogenic signal. The effect that predominates depends on the intensity of the signal and the context or tissue in which the signal is aberrantly activated. Genomic profiling of tumors has revealed common mutations in MAPK/ERK pathway components, such as v-raf murine sarcoma viral oncogene homolog B1 (BRAF). Currently approved for the treatment of melanoma, inhibitors of BRAF kinase are being studied alone and in combination with inhibitors of the MAPK and other pathways to optimize the treatment of many tumor types. Therapies targeted toward MAPK/ERK components have various response rates when used in different solid tumors, such as colorectal cancer and ovarian cancer. Understanding the differential nature of activation of the MAPK/ERK pathway in each tumor type is critical in developing single and combination regimens, because different tumors have unique mechanisms of primary and secondary signaling and subsequent sensitivity to drugs.

Understanding MAPK Signaling Pathways in Apoptosis

The Apoptotic Pathways and Their Mechanisms

MAPK/JNK Signalling: a Potential Autophagy Regulation Pathway

Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival

MAPK/JNK signaling: A potential autophagy regulation pathway.

Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

Mitogen-Activated Protein Kinase Signal Transduction in Solid Tumors

p38MAPK Signal Transduction Pathway and Cell Apoptosis

MAPK Signaling in Inflammation-Associated Cancer Development

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

Study Progress of Mitochondria or Cytochrome C-mediated Apoptosis Pathway

Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy

The MAPK pathway across different malignancies: A new perspective

Apoptosis: A Review of Programmed Cell Death

The regulatory and signaling mechanisms of the ASK family

The Critical Molecular Interconnections in Regulating Apoptosis and Autophagy

JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species

Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and P38 Signaling Pathways

JNK signaling in apoptosis

Mitochondria as multifaceted regulators of cell death